Posted by: admin on: March 7, 2012
With increase in life expectancy post menopausal osteoporosis needs to be attended to with life long maintenance drug to increase one’s BMD. In this article Raloxifene’s long term efficiency has been proved. Team@CMHF
Posted by: admin on: December 6, 2011
A selective estrogen receptor modulator (SERM) bazedoxifene is on the trial, to be approved as a drug for prevention of postmenopausal osteoporosis. Here is an article showing the clinical efficacy and safety of bazedoxifene in the treatment of postmenopausal osteoporosis. Team@CMHF
Posted by: admin on: October 12, 2011
Despite new guidelines and updated tools, diagnosing and treating patients with osteoporosis remains a challenge, a speaker said here. Nelson B. Watts, MD, professor of medicine at the University of Cincinnati College of Medicine, said today “there are new guidelines on calcium and vitamin D, new recommendations for testing for postmenopausal osteoporosis and new concerns […]
Posted by: admin on: August 24, 2011
Osteoporosis is a bone disorder characterized by low bone density, impaired bone architecture, and compromised bone strength that predisposes people to increased fracture risk. Osteoporosis is a major health concern worldwide and for many Americans 50 years of age and older. The prevalence of osteoporosis rises dramatically with age. It has been estimated that the […]
Posted by: admin on: August 4, 2011
At the age of 56, Jules Levin felt pretty invincible, despite being HIV positive. He went to the gym regularly and controlled his disease well by taking his antiretroviral medicines every day. Then he slipped one day while on vacation and broke his wrist. He underwent an operation to insert pins in his bones and […]